BIOMARKERS OF CARDIOMETABOLIC RISK, INFLAMMATION AND DISEASE

BIOMARKERS OF CARDIOMETABOLIC RISK, INFLAMMATION AND DISEASE

Editorial:
SPRINGER
Año de edición:
Materia
Medicina Interna
ISBN:
978-3-319-16018-4
Páginas:
165
N. de edición:
1
Idioma:
Inglés
Ilustraciones:
11
Disponibilidad:
Disponible en 2-3 semanas

Descuento:

-5%

Antes:

124,80 €

Despues:

118,56 €

Inflammation Biomarkers and Cardiometabolic Risk
Reis, Flávio (et al.)
Pages 1-24
Cardiovascular Disease
Fernandes, Andreia (et al.)
Pages 25-53
Diabetes Mellitus and Metabolic Syndrome
Ortega, Eduardo (et al.)
Pages 55-79
Ischemic Stroke
Fonseca, Ana Catarina (et al.)
Pages 81-94
Chronic Kidney Disease
Santos-Silva, Alice (et al.)
Pages 95-111
Immune-Mediated Inflammatory Rheumatic Diseases
Santos, Maria José (et al.)
Pages 113-132
Cardiometabolic Risk, Inflammation, and Neurodegenerative Disorders
Palavra, Filipe (et al.)

- Systematic coverage of advances in cardiometabolic risk research
- Compares emergent and classical cardiometabolic risk biomarkers
- Discusses clinical relevance of cardiometabolic risk

This book discusses recent advances in the area of cardiometabolic risk biomarkers of
chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic
manner, the book starts with an introduction to cardiometabolic risk and its clinical
relevance, comparing emergent and classical biomarkers. It then goes on to discuss
cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke
and neurodegenerative disorders.
Biomarkers of Cardiometabolic Risk, Inflammation and Disease is aimed at doctors
specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or
endocrinology and will also be of interest to GPs, trainee doctors, and clinical and basic
researchers working on cardiovascular and autoimmune disorders.

Authors
Filipe Palavra, MD
Laboratory of Pharmacology and Experimental Therapeutics
Institute for Biomedical Imaging and Life Sciences (IBILI)
Faculty of Medicine, Coimbra University
Coimbra, Portugal
Flávio Reis, PhD
Laboratory of Pharmacology and Experimental Therapeutics
Institute for Biomedical Imaging and Life Sciences (IBILI)
Faculty of Medicine, Coimbra University
Coimbra, Portugal
Daniela Marado, MD
Department of Internal Medicine – B
Centro Hospitalar e Universitário de Coimbra
Coimbra, Portugal
Armando Sena, MD, PhD
Interdisciplinary Centre of Research Egas Moniz, CiiEM
Caparica, Portugal

Otros libros del autor